Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safflower injection and salvia miltiorrhiza injection for focal bone infarction of the knee
ChiCTR-TRC-11001911Phase 4Completed
- Sponsor
- Southwest Health System
- Start
- Jan 2008
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Honghua Injection and salvia miltiorrhiza in Bone Infarction (2 arms), sponsored by Southwest Health System. Primary endpoints: Lysholm score of the knee and AKS score of the knee. Started Jan 2008; status: completed.
02
Drugs
Honghua Injectionsalvia miltiorrhiza
03
Conditions
Bone Infarction
Beyond the preview
Go deeper on ChiCTR-TRC-11001911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001911.